Archean Chemical Industries Limited has announced its Q3FY26 financial results, showing significant declines across key profitability metrics despite revenue growth. The company reported a standalone net profit of ₹343 million for the third quarter, representing a 39.08% decrease from ₹563 million in the corresponding quarter of the previous year. However, the company managed to achieve revenue growth with quarterly sales reaching ₹2.5 billion compared to ₹2.4 billion in the same period last year.

Q3FY26 Financial Performance

The latest quarterly results present challenging operational conditions for the chemical manufacturer, with both profitability and operational efficiency under pressure. The company's EBITDA for Q3 stood at ₹589 million, marking a significant 30.04% decline from ₹842 million in the corresponding quarter of the previous year. The EBITDA margin also compressed substantially to 23.58% from 34.72% in the same period last year, indicating margin pressure across operations.

Board Meeting and Results Approval

The financial results were reviewed and approved by the company's board of directors during their meeting held on February 04, 2026, in Chennai. The board meeting was conducted in compliance with Regulation 29(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Earnings Call and Management Discussion

Following the results announcement, the company conducted an earnings call on February 06, 2026, at 11:30 AM IST to discuss the operational and financial performance with investors and analysts. The call was attended by senior management including Mr. Ranjit Pendurthi (Executive Vice Chairman), Mr. Rampraveen Swaminathan (Managing Director), Mr. Nagayanallur Ramachandran Kannan (Executive Director), Mr. Natarajan Ramamurthy (Chief Financial Officer), and Mr. Rajeev Kumar (DGM Finance).

Regulatory Compliance

Archean Chemical Industries Limited has ensured full regulatory compliance by forwarding copies of the unaudited financial results to the stock exchanges immediately after the board meeting. The company has also published the financial results as mandated under Regulation 47 of SEBI LODR, with all information made available on the company's official website at www.archeanchemicals.com . The trading window for designated persons and their immediate relatives, which was closed from December 26, 2025, reopened following the results announcement on February 06, 2026.

Archean Chemical Industries has received disclosure from its promoter Chemikas Speciality LLP regarding the pledge of 9,50,000 equity shares under SEBI regulations. The pledge was created on January 22, 2026, with the formal disclosure made to BSE Limited and National Stock Exchange of India Limited on January 27, 2026.

Pledge Details and Transaction Structure

The pledged shares serve as collateral for loans, with Bajaj Financial Securities Ltd. being the beneficiary entity. This latest pledge represents 0.77% of the company's total share capital and increases the promoter's overall encumbered shareholding.

Promoter Shareholding Analysis

Chemikas Speciality LLP maintains a significant stake in Archean Chemical Industries, with the pledge forming part of its broader shareholding structure. The promoter's total holding and encumbrance details reflect its financial arrangements and commitment to the company.

Regulatory Compliance and Disclosure

The disclosure was made pursuant to Regulation 31 of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which mandates promoters to inform stock exchanges about encumbrance of shares. The formal communication was signed by P. Ranjit, Partner of Chemikas Speciality LLP, from Chennai.

The company's shares are listed on both BSE Limited (Scrip Code: 543657) and National Stock Exchange of India Limited (Symbol: ACI). Other promoter entities, including P Ranjit who holds 2,82,65,965 shares (22.90% of total share capital), have not created any encumbrances on their holdings as per the current disclosure.

Impact on Shareholding Structure

With this pledge, Chemikas Speciality LLP's encumbered shareholding has increased from 4.94% to 5.71% of the total share capital. The promoter group continues to maintain substantial ownership in Archean Chemical Industries, with the pledge arrangement facilitating access to financing while retaining ownership rights in the underlying shares.